New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
08:14 EDTBMRNBioMarin price target raised to $84 from $78 at Leerink
Leerink raised its price target for BioMarin shares to $84 after its physician survey indicated a more rapid uptake of Vimizim for Morquio syndrome than it had modeled. The firm keeps an Outperform rating on the stock.
News For BMRN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 2, 2016
08:36 EDTBMRNPiper Jaffray biopharma analyst holds an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use